Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat

Neuroscience Letters

Volumn 218, Issue 1, 1996, Pages 41-44

  Dawson, Deborah A ^a   Martin, David ^b   Hallenbeck, John M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b AMGEN INC   (United States)

Author keywords

Fluorescence microscopy; Focal cerebral ischemia; Microcirculation; Neuroprotection; Tumor necrosis factor alpha; Type I soluble tumor necrosis factor receptor

Indexed keywords

NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030601808     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)13116-5     Document Type: Article

References (20)

1. [1] Barone, F.C., Arvin, B., White, R.F., Webb, C.L., Lysko, P.G. and Feuerstein, G.Z., Tumor necrosis factor α in experimental stroke, Stroke, 27 (1996) S24.
2. [2] Bruce, A.J., Boling, W.B., Kindy, M.S., Peschon, J., Kraemer, P.J., Carpenter, M.K., Holtsberg, F.W. and Mattson, M.P., Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors, Nature Med., 2 (1996) 788-794.
3. [3] Buttini, M., Appel, K., Sauter, A., Gebicke-Haerter, P.-J. and Boddeke, H.W.G.M., Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat, Neuroscience, 71 (1996) 1-16.
4. [4] Engelmann, H., Novick, D. and Wallach, D., Two tumor necrosis binding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors, J. Biol. Chem., 265 (1990) 1531-1542.
5. [5] Estrada, C., Gomez, C. and Martin, C., Effects of TNF-α on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture, J. Cerebral Blood Flow Metab., 15 (1995) 920-928.
6. [6] Feuerstein, G.Z., Liu, T. and Barone, F.C., Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha, Cerebrovasc. Brain Metab. Rev., 6 (1994) 341-360.
7. [7] Garcia, J.H., Liu, K.-F., Yoshida, Y., Chen, S. and Lian, J., Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat), Am. J. Pathol., 145 (1994) 728-740.
8. [8] Gobel, U., Theilen, H. and Kuschinsky, W., Congruence of total and perfused capillary network in rat brains, Circ. Res., 66 (1990) 271-281.
9. [9] Kaplan, B., Brint, S., Tanabe, J., Lacewicz, M., Wang, X.J. and Pulsinelli, W., Temporal thresholds for neocortical infarction in rats subjected to reversible focal ischemia, Stroke, 22 (1991) 1032-1039.
10. [10] Liu, T., Clark, R.K., McDonnell, P.C., Young, P.R., White, R.F., Barone, F.C. and Feuerstein, G.Z., Tumor necrosis factor-α expression in ischemic neurons, Stroke, 25 (1994) 1481-1488.
11. [11] Martin, D., Near, S.L., Bendele, A. and Russell, D.A., Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein, Exp. Neurol., 131 (1995) 221-228.
12. [12] Megyeri, P., Abraham, C.S., Temesvari, P., Kovacs, J., Vas, T. and Speer, C.P., Recombinant human tumor necrosis factor α constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets, Neurosci. Lett., 148 (1992) 137-140.
13. [13] Mori, E., del Zoppo, G.J., Chambers, D., Copeland, B.R. and Arfors, K.E., Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons, Stroke, 23 (1992) 712-718.
14. [14] Nawashiro, H., Martin, D. and Hallenbeck, J.M., Inhibition of tumor necrosis factor ameliorates brain infarction in mice, J. Cerebral Blood Flow Metab. (1996) in press.
15. [15] Osborne, K.A., Shigeno, T., Balarsky, A.M., Ford, I., McCulloch, J., Teasdale, G.M. and Graham, D.I., Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia, J. Neurol. Neurosurg., Psychiatry, 50 (1987) 402-410.
16. [16] Rothwell, N.J. and Relton, J.K., Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage, Cerebrovasc. Brain Metab. Rev., 5 (1993) 178-198.
17. [17] Shohami, E., Bass, R., Wallach, D., Yamin, A. and Gallily, R., Inhibition of tumor necrosis factor alpha (TNFα) activity in rat brain is associated with cerebroprotection after closed head injury, J. Cerebral Blood Flow Metab., 16 (1996) 378-384.
18. [18] Siren, A.-L., Heldman, E., Doron, D., Lysko, P.G., Yue, T.-L., Liu, Y., Feuerstein, G. and Hallenbeck, J.M., Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats, Stroke, 23 (1992) 1643-1651.
19. [19] Swanson, R.A. and Sharp, F.R., BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage, Stroke, 25 (1994) 225.
20. [20] Tureen, J., Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide, J. Clin. Invest., 9 (1995) 1086-1091.